Positive News Sentiment NASDAQ:TRHC Tabula Rasa HealthCare - TRHC Stock Forecast, Price & News Adding Choose a watchlist: Watchlist Adding You have already added five stocks to your watchlist. Upgrade to MarketBeat Daily Premium to add more stocks to your watchlist. Adding Tabula Rasa HealthCare, Inc. Please log in to your account or sign up in order to add this asset to your watchlist. $5.00 -0.16 (-3.10%) (As of 03/24/2023 12:00 AM ET) Add Compare Share Share Today's Range$4.83▼$5.1550-Day Range$4.91▼$6.5152-Week Range$2.09▼$6.69Volume525,115 shsAverage Volume87,271 shsMarket Capitalization$134.35 millionP/E RatioN/ADividend YieldN/APrice Target$5.50 ProfileAnalyst RatingsChartCompetitorsEarningsFinancialsInsider TradesInstitutional OwnershipHeadlinesOptions ChainSEC FilingsShort InterestSocial Media Tabula Rasa HealthCare MarketRank™ ForecastAnalyst RatingHold2.00 Rating ScoreUpside/Downside10.0% Upside$5.50 Price TargetShort InterestBearish7.00% of Float Sold ShortDividend StrengthN/ASustainabilityN/ANews SentimentN/AInsider TradingN/AProj. Earnings GrowthGrowingFrom ($0.93) to ($0.67) Per ShareSee Full Details Hide Full Details Overall MarketRank™MarketRank is calculated as an average of available category scores, with extra weight given to analysis and valuation.1.13 out of 5 starsMedical Sector986th out of 1,005 stocksBusiness Services, Not Elsewhere Classified Industry91st out of 92 stocks 1.0 Analyst's Opinion Consensus RatingTabula Rasa HealthCare has received a consensus rating of Hold. The company's average rating score is 2.00, and is based on no buy ratings, 3 hold ratings, and no sell ratings.Price Target Upside/DownsideAccording to analysts' consensus price target of $5.50, Tabula Rasa HealthCare has a forecasted upside of 10.0% from its current price of $5.00.Amount of Analyst CoverageTabula Rasa HealthCare has received no research coverage in the past 90 days. Previous Next 1.0 Short Interest Percentage of Shares Shorted7.00% of the float of Tabula Rasa HealthCare has been sold short.Short Interest Ratio / Days to CoverTabula Rasa HealthCare has a short interest ratio ("days to cover") of 20.7, which indicates bearish sentiment.Change versus previous monthShort interest in Tabula Rasa HealthCare has recently decreased by 2.30%, indicating that investor sentiment is improving. Previous Next 0.0 Dividend Strength Dividend YieldTabula Rasa HealthCare does not currently pay a dividend.Dividend GrowthTabula Rasa HealthCare does not have a long track record of dividend growth. Previous Next N/A Sustainability and ESG Overall ESG (Environmental, Social, and Governance) ScoreThere is no current Upright™ data available for TRHC. Previous Next 3.3 News and Social Media Coverage News SentimentTabula Rasa HealthCare has a news sentiment score of 1.87. This score is calculated as an average of sentiment of articles about the company over the last seven days and ranges from 2 (good news) to -2 (bad news). This is a higher news sentiment than the 0.75 average news sentiment score of Medical companies.News Coverage This WeekMarketBeat has tracked 1 news article for Tabula Rasa HealthCare this week, compared to 1 article on an average week.Search Interest7 people have searched for TRHC on MarketBeat in the last 30 days. MarketBeat FollowsOnly 2 people have added Tabula Rasa HealthCare to their MarketBeat watchlist in the last 30 days. This is a decrease of -75% compared to the previous 30 days. Previous Next 1.7 Company Ownership Insider Buying vs. Insider SellingIn the past three months, Tabula Rasa HealthCare insiders have not sold or bought any company stock.Percentage Held by InsidersOnly 7.25% of the stock of Tabula Rasa HealthCare is held by insiders.Percentage Held by Institutions60.90% of the stock of Tabula Rasa HealthCare is held by institutions. High institutional ownership can be a signal of strong market trust in this company. Previous Next 0.6 Earnings and Valuation Earnings GrowthEarnings for Tabula Rasa HealthCare are expected to grow in the coming year, from ($0.93) to ($0.67) per share.Price to Earnings Ratio vs. the MarketThe P/E ratio of Tabula Rasa HealthCare is -0.82, which means that its earnings are negative and its P/E ratio cannot be compared to companies with positive earnings.Price to Earnings Ratio vs. SectorThe P/E ratio of Tabula Rasa HealthCare is -0.82, which means that its earnings are negative and its P/E ratio cannot be compared to companies with positive earnings. Previous Next See Top Rated MarketRank™ Stocks Here About Tabula Rasa HealthCare (NASDAQ:TRHC) StockTabula Rasa Healthcare, Inc. is a healthcare technology company, which engages in the development of solutions designed for pharmacists, providers, and patients to optimize medication regimens. It operates through the following segments: CareVention HealthCare and MedWise HealthCare. The CareVention HealthCare segment provides services, PACE, which is a center for Medicare & Medicaid services, or CMS, sponsored program providing medical and social services. Its brands include CareKinesis, Capstone Risk Adjustment Services, PACElogic, TruChart, PeakTPA, PersonifilRx, and Pharmastar. The MedWise HealthCare segment provides Medication Therapy Management, or MTM, software and services for Medicare, Medicaid, and commercial health plans, and also provides a cloud-based patient engagement software and services. It offers cloud-based software and clinical pharmacist services through its brands, including MedWise, SinfoníaRx, RxCompanion, PrescribeWellness, and DoseMeRx. The company was founded by Calvin H. Knowlton, Orsula V. Knowlton, and Michael Greenhalgh in April 2009 and is headquartered in Moorestown, NJ.Read More Receive TRHC Stock News and Ratings via Email Sign-up to receive the latest news and ratings for Tabula Rasa HealthCare and its competitors with MarketBeat's FREE daily newsletter. Email Address TRHC Stock News HeadlinesMarch 16, 2023 | americanbankingnews.comStockNews.com Begins Coverage on Tabula Rasa HealthCare (NASDAQ:TRHC)March 8, 2023 | markets.businessinsider.comAnalysts Offer Insights on Technology Companies: Keysight Technologies (KEYS), Tabula Rasa HealthCare (TRHC) and CrowdStrike Holdings (CRWD)March 26, 2023 | Weiss Ratings (Ad)Fed's Shocking New Plan to Control Your MoneyThe Federal Reserve has a disturbing plan that is getting ready to roll out as soon as May. This is a lot more than printing trillions of dollars or manipulating interest rates. It's about every checking account, every purchase and every money transfer in America — including yours and mine. March 8, 2023 | finance.yahoo.comTabula Rasa HealthCare, Inc. (NASDAQ:TRHC) Q4 2022 Earnings Call TranscriptMarch 8, 2023 | finance.yahoo.comOwning 42% shares,institutional owners seem interested in Tabula Rasa HealthCare, Inc. (NASDAQ:TRHC),March 8, 2023 | finance.yahoo.comQ4 2022 Tabula Rasa HealthCare Inc Earnings CallMarch 7, 2023 | bizjournals.comTabula Rasa takes $57M loss on divestitures, completes sales of 3 non-core businessesMarch 6, 2023 | msn.comTabula Rasa HealthCare GAAP EPS of -$0.74 misses by $0.31, revenue of $82.71M beats by $1.9MMarch 26, 2023 | Weiss Ratings (Ad)Fed's Shocking New Plan to Control Your MoneyThe Federal Reserve has a disturbing plan that is getting ready to roll out as soon as May. This is a lot more than printing trillions of dollars or manipulating interest rates. It's about every checking account, every purchase and every money transfer in America — including yours and mine. March 6, 2023 | markets.businessinsider.comTabula Rasa HealthCare Reports Fourth Quarter and Full Year 2022 Financial ResultsMarch 5, 2023 | markets.businessinsider.comHere's what Wall Street expects from Tabula Rasa HealthCare's earningsMarch 3, 2023 | msn.comPreview: Tabula Rasa HealthCare's EarningsMarch 3, 2023 | finance.yahoo.comMedication Management Services Leader Cureatr Acquires SinfoníaRxMarch 3, 2023 | finanznachrichten.deTabula Rasa HealthCare, Inc.: Tabula Rasa HealthCare Completes the Sale of SinfoníaRx and DoseMeRxMarch 3, 2023 | finance.yahoo.comTabula Rasa HealthCare Completes the Sale of SinfoníaRx and DoseMeRxFebruary 21, 2023 | finance.yahoo.comTabula Rasa HealthCare Schedules Fourth Quarter and Full Year 2022 Earnings Conference CallJanuary 26, 2023 | finance.yahoo.comQuite a few insiders invested in Tabula Rasa HealthCare, Inc. (NASDAQ:TRHC) last year which is positive news for shareholdersJanuary 19, 2023 | finance.yahoo.comNewsweek Names Tabula Rasa HealthCare Among America's Greatest Workplaces for DiversityJanuary 19, 2023 | markets.businessinsider.comStifel Nicolaus Reaffirms Their Hold Rating on Tabula Rasa HealthCare (TRHC)January 17, 2023 | finance.yahoo.comTabula Rasa HealthCare Announces Preliminary Estimated Fourth Quarter 2022 Revenues From Continuing OperationsDecember 30, 2022 | finance.yahoo.comInvestors in Tabula Rasa HealthCare (NASDAQ:TRHC) have unfortunately lost 90% over the last three yearsDecember 20, 2022 | seekingalpha.comTabula Rasa HealthCare Is Dead MoneyNovember 22, 2022 | finance.yahoo.comMoorestown megamansion lists for $24.95M, becomes most expensive home ever listed in South JerseyNovember 17, 2022 | finance.yahoo.comPushing out husband-and-wife founders cost Tabula Rasa more than $8M, SEC filings showNovember 9, 2022 | finance.yahoo.comTabula Rasa HealthCare Third Quarter 2022 Earnings: Revenues Beat Expectations, EPS LagsNovember 4, 2022 | seekingalpha.comTabula Rasa HealthCare, Inc. (TRHC) Q3 2022 Earnings Call TranscriptNovember 4, 2022 | finance.yahoo.comTabula Rasa HealthCare Reports Third Quarter 2022 ResultsSee More Headlines View Price History Chart DataSkip Price History Chart 30 days | 90 days | 365 days | Advanced Chart Receive TRHC Stock News and Ratings via Email Sign-up to receive the latest news and ratings for Tabula Rasa HealthCare and its competitors with MarketBeat's FREE daily newsletter. Email Address TRHC Company Calendar Last Earnings11/04/2021Today3/26/2023Next Earnings (Estimated)5/04/2023Fiscal Year End12/31/2023Get Stock AlertsIndustry, Sector and Symbol Stock ExchangeNASDAQ Industry Business services, not elsewhere classified Sub-IndustryN/A SectorMedical Current SymbolNASDAQ:TRHC CUSIPN/A CIK1651561 Webwww.tabularasahealthcare.com Phone(866) 648-2767FaxN/AEmployees1,027Year FoundedN/APrice Target and Rating Average Stock Price Forecast$5.50 High Stock Price Forecast$6.00 Low Stock Price Forecast$5.00 Forecasted Upside/Downside+10.0%Consensus RatingHold Rating Score (0-4)2.00 Research Coverage3 Analysts Profitability EPS (Most Recent Fiscal Year)($6.09) Trailing P/E RatioN/A Forward P/E RatioN/A P/E GrowthN/ANet Income$-147,510,000.00 Net Margins-49.25% Pretax Margin-25.69% Return on Equity-472.90% Return on Assets-12.86% Debt Debt-to-Equity RatioN/A Current Ratio1.67 Quick Ratio1.60 Sales & Book Value Annual Sales$299.52 million Price / Sales0.45 Cash FlowN/A Price / Cash FlowN/A Book Value($2.10) per share Price / Book-2.38Miscellaneous Outstanding Shares26,870,000Free Float24,923,000Market Cap$134.35 million OptionableOptionable Beta1.54 Key ExecutivesBrian W. AdamsPresident & Chief Executive OfficerMichael GreenhalghChief Operating OfficerThomas J. CancroChief Financial & Accounting OfficerJoseph J. FilippoliChief Information OfficerJacques TurgeonChief Scientific OfficerKey CompetitorsGlobal System DynamicsNASDAQ:GSDCue BiopharmaNASDAQ:CUESema4NASDAQ:SMFRCitius PharmaceuticalsNASDAQ:CTXROlema PharmaceuticalsNASDAQ:OLMAView All CompetitorsInsiders & InstitutionsMillennium Management LLCSold 144,595 shares on 2/15/2023Ownership: 1.194%Morgan StanleySold 4,161 shares on 2/15/2023Ownership: 0.094%Schonfeld Strategic Advisors LLCSold 12,300 shares on 2/15/2023Ownership: 0.055%Two Sigma Investments LPSold 118,420 shares on 2/14/2023Ownership: 0.722%PDT Partners LLCSold 21,751 shares on 2/14/2023Ownership: 0.050%View All Insider TransactionsView All Institutional Transactions TRHC Stock - Frequently Asked Questions Should I buy or sell Tabula Rasa HealthCare stock right now? 3 Wall Street analysts have issued "buy," "hold," and "sell" ratings for Tabula Rasa HealthCare in the last year. There are currently 3 hold ratings for the stock. The consensus among Wall Street analysts is that investors should "hold" TRHC shares. A hold rating indicates that analysts believe investors should maintain any existing positions they have in TRHC, but not buy additional shares or sell existing shares. View TRHC analyst ratings or view top-rated stocks. What is Tabula Rasa HealthCare's stock price forecast for 2023? 3 Wall Street analysts have issued 12 month price targets for Tabula Rasa HealthCare's shares. Their TRHC share price forecasts range from $5.00 to $6.00. On average, they predict the company's stock price to reach $5.50 in the next twelve months. This suggests a possible upside of 10.0% from the stock's current price. View analysts price targets for TRHC or view top-rated stocks among Wall Street analysts. How have TRHC shares performed in 2023? Tabula Rasa HealthCare's stock was trading at $4.95 at the beginning of 2023. Since then, TRHC shares have increased by 1.0% and is now trading at $5.00. View the best growth stocks for 2023 here. When is Tabula Rasa HealthCare's next earnings date? The company is scheduled to release its next quarterly earnings announcement on Thursday, May 4th 2023. View our TRHC earnings forecast. How were Tabula Rasa HealthCare's earnings last quarter? Tabula Rasa HealthCare, Inc. (NASDAQ:TRHC) issued its quarterly earnings data on Thursday, November, 4th. The company reported ($0.04) earnings per share for the quarter, beating the consensus estimate of ($0.19) by $0.15. The firm had revenue of $86.60 million for the quarter, compared to analysts' expectations of $88.54 million. Tabula Rasa HealthCare had a negative net margin of 49.25% and a negative trailing twelve-month return on equity of 472.90%. The business's revenue for the quarter was up 22.8% compared to the same quarter last year. During the same period last year, the company posted ($0.35) EPS. What guidance has Tabula Rasa HealthCare issued on next quarter's earnings? Tabula Rasa HealthCare updated its first quarter 2023 earnings guidance on Monday, March, 6th. The company provided earnings per share guidance of for the period. The company issued revenue guidance of $82.00 million-$84.00 million, compared to the consensus revenue estimate of $76.27 million. What is Calvin H. Knowlton, BScPharm, MDiv, PhD's approval rating as Tabula Rasa HealthCare's CEO? 24 employees have rated Tabula Rasa HealthCare Chief Executive Officer Calvin H. Knowlton, BScPharm, MDiv, PhD on Glassdoor.com. Calvin H. Knowlton, BScPharm, MDiv, PhD has an approval rating of 91% among the company's employees. This puts Calvin H. Knowlton, BScPharm, MDiv, PhD in the top 30% of approval ratings compared to other CEOs of publicly-traded companies. What other stocks do shareholders of Tabula Rasa HealthCare own? Based on aggregate information from My MarketBeat watchlists, some companies that other Tabula Rasa HealthCare investors own include NVIDIA (NVDA), Advanced Micro Devices (AMD), QUALCOMM (QCOM), Adobe (ADBE), Micron Technology (MU), Boeing (BA), Salesforce (CRM), Intel (INTC) and Netflix (NFLX). When did Tabula Rasa HealthCare IPO? (TRHC) raised $60 million in an initial public offering on Thursday, September 29th 2016. The company issued 4,300,000 shares at a price of $13.00-$15.00 per share. Wells Fargo Securities, UBS Investment Bank and Piper Jaffray served as the underwriters for the IPO and Baird and Stifel were co-managers. What is Tabula Rasa HealthCare's stock symbol? Tabula Rasa HealthCare trades on the NASDAQ under the ticker symbol "TRHC." Who are Tabula Rasa HealthCare's major shareholders? Tabula Rasa HealthCare's stock is owned by many different institutional and retail investors. Top institutional investors include UBS Group AG (4.80%), Fuller & Thaler Asset Management Inc. (1.30%), Millennium Management LLC (1.19%), Spears Abacus Advisors LLC (0.90%), Geode Capital Management LLC (0.87%) and Bank of Montreal Can (0.81%). Insiders that own company stock include Andrea Carolan Speers, Brian W Adams, Calvin H Knowlton, Dennis Helling, Gordon Tunstall, Indaba Capital Management, LP, Jan Berger, Michael Greenhalgh, Michael J Purcell, Orsula V Knowlton, Orsula V Knowlton, Samira Beckwith and Thomas Cancro. View institutional ownership trends. How do I buy shares of Tabula Rasa HealthCare? Shares of TRHC stock can be purchased through any online brokerage account. Popular online brokerages with access to the U.S. stock market include WeBull, Vanguard Brokerage Services, TD Ameritrade, E*TRADE, Robinhood, Fidelity, and Charles Schwab. Compare Top Brokerages Here. What is Tabula Rasa HealthCare's stock price today? One share of TRHC stock can currently be purchased for approximately $5.00. How much money does Tabula Rasa HealthCare make? Tabula Rasa HealthCare (NASDAQ:TRHC) has a market capitalization of $134.35 million and generates $299.52 million in revenue each year. The company earns $-147,510,000.00 in net income (profit) each year or ($6.09) on an earnings per share basis. How many employees does Tabula Rasa HealthCare have? The company employs 1,027 workers across the globe. How can I contact Tabula Rasa HealthCare? Tabula Rasa HealthCare's mailing address is 228 STRAWBRIDGE DRIVE SUITE 100, MOORESTOWN NJ, 08057. The official website for the company is www.tabularasahealthcare.com. The company can be reached via phone at (866) 648-2767 or via email at tabularasa@westwicke.com. This page (NASDAQ:TRHC) was last updated on 3/26/2023 by MarketBeat.com Staff Get 30 Days of MarketBeat All Access Free Sign up for MarketBeat All Access to gain access to MarketBeat's full suite of research tools: Best-in-Class Portfolio Monitoring View the latest news, buy/sell ratings, SEC filings and insider transactions for your stocks. Compare your portfolio performance to leading indices and get personalized stock ideas based on your portfolio. Stock Ideas and Recommendations Get daily stock ideas from top-performing Wall Street analysts. Get short term trading ideas from the MarketBeat Idea Engine. View which stocks are hot on social media with MarketBeat's trending stocks report. Advanced Stock Screeners and Research Tools Identify stocks that meet your criteria using seven unique stock screeners. See what's happening in the market right now with MarketBeat's real-time news feed. Export data to Excel for your own analysis. Start Your 30-Day Free Trial Sign in to your free account to enjoy these benefits In-depth profiles and analysis for 20,000 public companies. Real-time analyst ratings, insider transactions, earnings data, and more. Our daily ratings and market update email newsletter. Sign in to your free account to enjoy all that MarketBeat has to offer. Sign In Create Account Your Email Address: Your Password: or Sign in with Facebook Sign in with Google Forgot your password? Your Email Address: Choose a Password: Create My Account (Free) or Sign in with Facebook Sign in with Google By creating a free account, you agree to our terms of service. This site is protected by reCAPTCHA and the Google Privacy Policy and Terms of Service apply.